Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GL-V9 is an AMPK activator, protecting against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | GL-V9 is an AMPK activator, protecting against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy. |
Molecular Weight | 409.47 |
Formula | C24H27NO5 |
CAS No. | 1178583-19-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GL-V9 1178583-19-1 FR 180204 negative control FR-180204 negative control QUN70738 ERK Inhibitor II, Negative Control FR180204 negative control QUN 70738 inhibitor inhibit